Sign in

Eric K. Singhi, MD

@lungoncdoc.bsky.social
1K followers 82 following 0 posts

Thoracic Medical Oncologist, Assistant Professor at MDAndersonNews | Passionate about patient education & young-onset lung cancer | 🫁 #cancer #lcsm #lcam #MedSky #Oncsky| Views my own.

PostsRepliesMedia
Reposted by Eric K. Singhi, MD
Oncogene Cancer Research @oncogenecancer.bsky.social · 16/03/2025
This is why biomarker testing is so important. Not all lung cancers are the same. Wonderful to see more and better options. Still don’t have cures. Thank you Dr @lungoncdoc.bsky.social for a great presentation @cancergrace.bsky.social Patient Forum #lcsm
Pie chart of lung cancer biomarkers and associated therapies
052
Reposted by Eric K. Singhi, MD
Lung Cancer Research Foundation @lcrf.org · 02/04/2025
In our next Together Separately livestream, Drs. Eric Singhi & Isabel Preeshagul will discuss the nuances of younger people navigating a #LungCancer diagnosis. Sign up to join us live Wed April 23 at 4 PM ET – you'll also get a link to the recording. LCRF.org/together2 @lungoncdoc.bsky.social
lcrf.org
Together Separately: Young Lung Cancer - Lung Cancer Research Foundation
Eric Singhi, MD will discuss the nuances and complexities of younger people receiving and navigating a lung cancer diagnosis. Join us live, or watch the recording afterwards, to learn more how this…
022
Reposted by Eric K. Singhi, MD
Florez Lab @florezlab.bsky.social · 03/04/2025
Exciting news! @curetoday.bsky.social is hosting an incredible Young-Onset Lung Cancer Summit 🎉 Chaired by the amazing @lungoncdoc.bsky.social, this is a must-attend event for anyone looking to learn more about @younglungcancer.bsky.social!
122
Reposted by Eric K. Singhi, MD
Lung Cancer Research Foundation @lcrf.org · 16/04/2025
On our next livestreams: a look at how #LungCancer affects young people and women, with moderator Dr. Isabel Preeshagul. Wed, April 23: Young Lung Cancer w/ Dr. Eric Singhi @lungoncdoc.bsky.social, LCRF.org/together2 Wed, May 14: Women & Lung Cancer w/ Dr. Narjust Florez, LCRF.org/together
073
Reposted by Eric K. Singhi, MD
EGFR Positive Lung Cancer UK @egfrpositiveuk.bsky.social · 21/12/2024
#ClinicalTrials can be tough to decode, but this excellent open-access guide makes it easier to understand terms like progression-free survival & others. We’ll def be sharing with our #EGFR #LungCancer community. Big 🙏 to @lungoncdoc.bsky.social & co! 👉 www.tandfonline.com/doi/full/10.... #LCSM
tandfonline.com
Decoding clinical trial jargon: helping people understand the efficacy end points used in cancer trials
People living with cancer should have access to clear and comprehensible treatment information to empower informed decision-making. With the increasing adoption of open access publishing and plain-...
074
Reposted by Eric K. Singhi, MD
Amy C. Moore, PhD @acmoorephd.bsky.social · 10/12/2024
Thanks, Dr. Eric Singhi @lungoncdoc.bsky.social, for putting together this compilation of all the 2024 FDA #lungcancer approvals! Progress is real! #LCSM
23312